Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer-specific mortality.

Although both PSA nadir (PSAn) and testosterone levels at PSA failure are known prognostic factors in men undergoing radiation therapy (RT) and androgen deprivation therapy (ADT) for unfavorable-risk prostate cancer (PC), it is unclear whether their prognostic significance is independent or overlapping.

The Clinical and Pathologic Relevance of a Prostate MRI Diagnosis of “Prostatitis” – Beyond the Abstract

Many articles about prostatitis start with obligatory language saying how “not much is known” about the etiology and treatment is frustrating. Perhaps that’s true if every man with pain between his nipples and knees is given antibiotics until they improve or go to the next doctor. Following the simple syndrome-based NIH classification system and evidence-based […]

SUFU 2021: Effect of the School Environment on the Presence of Lower Urinary Tract Symptoms in Adolescents

(UroToday.com) This was a cross-sectional, quantitative survey of adolescents to ascertain their perspective on urinary habits during school. The age of these volunteers ranged from 12-17 and they were recruited via ResearchMatch, a national health volunteer registry. A total of 2,627 volunteers received an email request to complete the survey with 39 completing the survey for […]

X